upadacitinib,adalimumab,methotrexate
abbvie
[' psa', 'ease,(-please),(-disease),(-incrrease),(-decrease)', ' upa ']
safety data from 9 phase 3 upa trials (ra, psa &amp; as). in 11,271 pt-yrs exposure, no increased signal for cancer (excluding nmsc) cf. ada/mtx. nmsc was higher however. what data (if any) would reassure people in this space? abst0292 #acr22 
Rheumatology nerd. Opinions are my own (except when wrong)